Opioid crisis to cost $2.15 trillion? ‘No amount of money can ever compensate for the pain’

In This Article:

U.S. states are claiming that opioid manufacturers, distributors, and others who fueled the country’s decades-long opioid crisis will cost the economy at least $2.15 trillion by the year 2040.

The figure was reported in a filing made public Monday in the Southern District of New York in the bankruptcy case for OxyContin maker Purdue Pharmaceutical.

“The opioid epidemic has ravaged this country as a single family has made billions profiting from the destruction it caused,” New York Attorney General Letitia James said in a statement emailed to Yahoo Finance. “The millions of families that have suffered as the result of addiction, ailments, and death can never be repaid for their losses, and no amount of money can ever compensate for the pain that so many now know.”

U.S. first lady Melania Trump visits a field of American flags, each flag representing a child in the foster system in Cabell County, WV, most of them due to the opioid crisis, at Ritter Park in Huntington, W.V., U.S., July 8, 2019. REUTERS/Al Drago     TPX IMAGES OF THE DAY
U.S. first lady Melania Trump visits a field of American flags, each flag representing a child in the foster system in Cabell County, WV, most of them due to the opioid crisis, on July 8, 2019. (Photo: REUTERS/Al Drago)

Between 2007 and 2019, the states estimated that their systems took a $630 billion hit. Anticipated costs of $1.53 trillion from 2020 to 2040 are estimated to run up the rest of the tab.

“As expected,” a Purdue spokesperson stated, “claims have been filed by a variety of private and public entities, including the states and territories, and it is typical for claims to be filed in amounts substantially larger than what is ultimately allowed by the court.”

The company, which filed for bankruptcy in September amid mounting lawsuits against opioid supply chain participants, proposed delivering more than $10 billion in value — including 100% of Purdue’s assets — toward claimants, communities, opioid addiction treatment, and overdose reversal medicines.

‘An extraordinary number of people are taking opioids’

In December 1995, the FDA approved a new opioid known as Oxycodone. Subsequently, according to the National Institute on Drug Abuse, “pharmaceutical companies reassured the medical community that patients would not become addicted to prescription opioid pain relievers, and health care providers began to prescribe them at greater rates.”

The cost of millions of Americans becoming addicted to prescription opioids on the country’s economy has not gone unnoticed. Last year, while testifying before the House Financial Services Committee, Federal Reserve Chair Jerome Powell spoke of its effects on the workforce.

“An extraordinary number of people are taking opioids in one form or another and it weighs on labor force participation,” Powell said. “It’s a national crisis, really. The humanitarian crisis of it is completely compelling but the economic impact is also quite substantial.”

Opioid prescribing rates, county-level U.S., 2014. (Source: CDC)
Opioid prescribing rates, county-level U.S., 2014. (Source: CDC)

The crisis has also cost a fortune in lost tax revenue: Between 2000 and 2016, “opioid misuse cost state governments $11.8 billion, including $1.7 billion in lost sales tax revenue and $10.1 billion in lost income tax revenue,” according to a study conducted by researchers at Penn State University. The study also found that the federal government lost $26 billion in income tax revenue during that time span.